Xylazine bill protects DVMs' access to sedative, AVMA saysJuly 21, 2023Language within the SUPPORT Act will schedule xylazine as a Schedule III drug, but allow continued use of the FDA-approved animal drug by veterinarians
SPONSORED CONTENTStart Treating Canine MMVD Patients at Stage B2Learn about early treatment with pimobendan for canine Stage B2 preclinical MMVD patients. + Learn More
